Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells. [electronic resource]
Producer: 20200217Description: 5823-5832 p. digitalISSN:- 1643-3750
- Adult
- Aged
- Carcinoma, Hepatocellular -- genetics
- Cell Movement -- genetics
- Cell Proliferation -- genetics
- Epithelial-Mesenchymal Transition -- genetics
- Female
- Gene Expression -- genetics
- Gene Expression Regulation, Neoplastic -- genetics
- Glycine Hydroxymethyltransferase -- genetics
- Hep G2 Cells
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Liver Neoplasms -- genetics
- Male
- Middle Aged
- Prognosis
- Transcriptome -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.